Abstract
Data on hepatic elimination of drugs in experimental uraemia and in uraemic patients indicate either the induction of hepatic enzymes or their inhibition /1–6/. Our paper concentrates on the evaluation of liver ability to biotransformation of drugs expressed by antipyrine elimination in uraemic patients regularly treated with peritoneal dialyses.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fine, A. and Summer, D. Proc. Eur. Dial. Transplant. Assoc. 11: 433–439, 1975.
Held, H. and Enderle, C. Clin. Nephrol. 6: 388–393, 1976.
Leber, H.W., Harders, A. and Schütterle, G. Klin. Wschr. 50: 1092–1096, 1972.
Lichter, M., Black, M. and Arias, I.M. J. Pharmacol. Exp. Ther. 187: 612–619, 1973.
Maddocks, J.L. Proc. Eur. Dial. Transplant. Assoc. 13: 624–631, 1976.
Reidenberg, M.M., Kostenbauder, H. and Adams, W.P. Metabolism 18: 209–212, 1969.
Brodie, B., Axelrod, J., Soberman, R. and Levy, B. J. Biol. Chem. 179: 25–30, 1949.
Fraser, H.S., Mucklow, J.C., Bulpitt, C.J., Khan, C., Mould, G. and Dollery, C.T. Clin. Pharmacol. Ther. 22: 799–808, 1977.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Grzegorzewska, A., Łowicki, Z., Chmara, E., Mrozikiewicz, A., Bączyk, K. (1989). Assessment of Liver Ability to Biotransformation of Antipyrine in Uraemic Patients on Regular Peritoneal Dialysis Treatment. In: Andreucci, V.E., Dal Canton, A. (eds) Current Therapy in Nephrology. Developments in Nephrology, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0865-2_111
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0865-2_111
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8209-9
Online ISBN: 978-1-4613-0865-2
eBook Packages: Springer Book Archive